2025-2031 Global Medical Inhaled Nitric Oxide Industry Research & Trends Analysis Report- YH Research

日本语 | 中文

Home > Reports >Medical Care > 2025-2031 Global Medical Inhaled Nitric Oxide Industry Research & Trends Analysis Report

2025-2031 Global Medical Inhaled Nitric Oxide Industry Research & Trends Analysis Report

Publication Date: 2025-07-09
Report Id: 2297794
Industry: Medical Care
Report Page: 117
Chart: 112

PDF Download

Publication Date: 2025-07-09
Report Id: 2297794
Industry: Medical Care
Report Page: 117
Chart: 112

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Medical Inhaled Nitric Oxide Definition
1.2 Global Medical Inhaled Nitric Oxide Market Size and Forecast
1.2.1 By Revenue, Global Medical Inhaled Nitric Oxide Market Size, 2020-2031
1.2.2 By Sales Volume, Global Medical Inhaled Nitric Oxide Market Size, 2020-2031
1.2.3 Global Medical Inhaled Nitric Oxide Price Trend, 2020-2031
1.3 China Medical Inhaled Nitric Oxide Market Size and Forecast
1.3.1 By Revenue, China Medical Inhaled Nitric Oxide Market Size, 2020-2031
1.3.2 By Sales Volume, China Medical Inhaled Nitric Oxide Market Size, 2020-2031
1.3.3 China Medical Inhaled Nitric Oxide Price Trend, 2020-2031
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Medical Inhaled Nitric Oxide Share in Global Market, 2020-2031
1.4.2 By Sales Volume, China Medical Inhaled Nitric Oxide Share in Global Market, 2020-2031
1.4.3 Medical Inhaled Nitric Oxide Market Size: China VS Global, 2020-2031
1.5 Medical Inhaled Nitric Oxide Market Dynamics
1.5.1 Medical Inhaled Nitric Oxide Market Drivers
1.5.2 Medical Inhaled Nitric Oxide Market Restraints
1.5.3 Medical Inhaled Nitric Oxide Industry Trends
1.5.4 Medical Inhaled Nitric Oxide Industry Policy

2 Global Competitive Landscape by Company
2.1 Global Medical Inhaled Nitric Oxide Revenue by Company, 2020-2025
2.2 Global Medical Inhaled Nitric Oxide Sales Volume by Company, 2020-2025
2.3 Global Medical Inhaled Nitric Oxide Price by Company, 2020-2025
2.4 Global Medical Inhaled Nitric Oxide Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Medical Inhaled Nitric Oxide Concentration Ratio
2.6 Global Medical Inhaled Nitric Oxide Mergers & Acquisitions, Expansion Plans
2.7 Global Medical Inhaled Nitric Oxide Manufacturers Product Type

3 China Competitive Landscape by Company
3.1 China Medical Inhaled Nitric Oxide Revenue by Company, 2020-2025
3.2 China Medical Inhaled Nitric Oxide Sales Volume by Company, 2020-2025
3.3 China Medical Inhaled Nitric Oxide Medical Inhaled Nitric Oxide Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.4 China Medical Inhaled Nitric Oxide Market, Sales Percentage of Local Players VS Foreign Players (2020-2025)
3.5 Chinese Local Players, Medical Inhaled Nitric Oxide Domestic VS Export
3.6 China Market, Medical Inhaled Nitric Oxide Import & Export
3.6.1 China Market, Medical Inhaled Nitric Oxide Import & Export, 2020-2031
3.6.2 China Medical Inhaled Nitric Oxide Import & Export Trends
3.6.3 Main Sources of China Medical Inhaled Nitric Oxide Import
3.6.4 Export Destination of China Medical Inhaled Nitric Oxide

4 Medical Inhaled Nitric Oxide Production by Region
4.1 Global Medical Inhaled Nitric Oxide Capacity, Production and Capacity Utilization, 2020-2031
4.2 Global Geographic Distribution of Medical Inhaled Nitric Oxide Manufacturers
4.3 Global Major Manufacturers, Medical Inhaled Nitric Oxide Capacity Expansion and Future Plans
4.4 Global Medical Inhaled Nitric Oxide Capacity by Region
4.5 Global Medical Inhaled Nitric Oxide Production by Region
4.5.1 Global Medical Inhaled Nitric Oxide Production & Forecast by Region, 2020 VS 2024 VS 2031
4.5.2 Global Medical Inhaled Nitric Oxide Production by Region, 2020-2025
4.5.3 Global Medical Inhaled Nitric Oxide Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Medical Inhaled Nitric Oxide Industry Chain
5.2 Medical Inhaled Nitric Oxide Upstream Analysis
5.2.1 Medical Inhaled Nitric Oxide Core Raw Materials
5.2.2 Main Manufacturers of Medical Inhaled Nitric Oxide Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Medical Inhaled Nitric Oxide Production Mode
5.6 Medical Inhaled Nitric Oxide Procurement Model
5.7 Medical Inhaled Nitric Oxide Industry Sales Model and Sales Channels
5.7.1 Medical Inhaled Nitric Oxide Sales Model
5.7.2 Medical Inhaled Nitric Oxide Typical Distributors

6 Sights by Product Type
6.1 Medical Inhaled Nitric Oxide Classification
6.1.1 High Purity iNO
6.1.2 Standard Purity iNO
6.2 by NO Concentration, Global Medical Inhaled Nitric Oxide Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by NO Concentration, Global Medical Inhaled Nitric Oxide Revenue, 2020-2031
6.4 by NO Concentration, Global Medical Inhaled Nitric Oxide Sales Volume, 2020-2031
6.5 by NO Concentration, Global Medical Inhaled Nitric Oxide Price, 2020-2031

7 Sights by Application
7.1 Medical Inhaled Nitric Oxide Segment by Application
7.1.1 Infants PPHN
7.1.2 ARDS, etc.
7.2 by Application, Global Medical Inhaled Nitric Oxide Market Size & CAGR, 2020 VS 2024 VS 2031
7.3 by Application, Global Medical Inhaled Nitric Oxide Revenue, 2020-2031
7.4 by Application, Global Medical Inhaled Nitric Oxide Sales Volume, 2020-2031
7.5 by Application, Global Medical Inhaled Nitric Oxide Price, 2020-2031

8 Sales Sights by Region
8.1 By Region, Global Medical Inhaled Nitric Oxide Market Size, 2020 VS 2024 VS 2031
8.2 By Region, Global Medical Inhaled Nitric Oxide Revenue, 2020-2031
8.3 By Region, Global Medical Inhaled Nitric Oxide Sales Volume, 2020-2031
8.4 North America
8.4.1 North America Medical Inhaled Nitric Oxide Market Size & Forecasts, 2020-2031
8.4.2 By Country, North America Medical Inhaled Nitric Oxide Market Size Market Share
8.5 Europe
8.5.1 Europe Medical Inhaled Nitric Oxide Market Size & Forecasts, 2020-2031
8.5.2 By Country, Europe Medical Inhaled Nitric Oxide Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Medical Inhaled Nitric Oxide Market Size & Forecasts, 2020-2031
8.6.2 By Country/Region, Asia Pacific Medical Inhaled Nitric Oxide Market Size Market Share
8.7 South America
8.7.1 South AmericaMedical Inhaled Nitric Oxide Market Size & Forecasts, 2020-2031
8.7.2 By Country, South America Medical Inhaled Nitric Oxide Market Size Market Share
8.8 Middle East & Africa

9 Sales Sights by Country Level
9.1 By Country, Global Medical Inhaled Nitric Oxide Market Size & CAGR，2020 VS 2024 VS 2031
9.2 By Country, Global Medical Inhaled Nitric Oxide Revenue, 2020-2031
9.3 By Country, Global Medical Inhaled Nitric Oxide Sales Volume, 2020-2031
9.4 United States
9.4.1 United States Medical Inhaled Nitric Oxide Market Size, 2020-2031
9.4.2 By Company, United States Medical Inhaled Nitric Oxide Sales Volume Market Share, 2024
9.4.3 by NO Concentration, United States Medical Inhaled Nitric Oxide Market Size, Share, 2024 VS 2031
9.4.4 by Application, United States Medical Inhaled Nitric Oxide Market Size, Share, 2024 VS 2031
9.5 Europe
9.5.1 Europe Medical Inhaled Nitric Oxide Market Size, 2020-2031
9.5.2 By Company, Europe Medical Inhaled Nitric Oxide Sales Volume Market Share, 2024
9.5.3 by NO Concentration, Europe Medical Inhaled Nitric Oxide Market Size, Share, 2024 VS 2031
9.5.4 by Application, Europe Medical Inhaled Nitric Oxide Market Size, Share, 2024 VS 2031
9.6 China
9.6.1 China Medical Inhaled Nitric Oxide Market Size, 2020-2031
9.6.2 By Company, China Medical Inhaled Nitric Oxide Sales Volume Market Share, 2024
9.6.3 by NO Concentration, China Medical Inhaled Nitric Oxide Market Size, Share, 2024 VS 2031
9.6.4 by Application, China Medical Inhaled Nitric Oxide Market Size, Share, 2024 VS 2031
9.7 Japan
9.7.1 Japan Medical Inhaled Nitric Oxide Market Size, 2020-2031
9.7.2 By Company, Japan Medical Inhaled Nitric Oxide Market Share, 2024
9.7.3 by NO Concentration, Japan Medical Inhaled Nitric Oxide Market Size, Share, 2024 VS 2031
9.7.4 by Application, Japan Medical Inhaled Nitric Oxide Market Size, Share, 2024 VS 2031
9.8 South Korea
9.8.1 South Korea Medical Inhaled Nitric Oxide Market Size, 2020-2031
9.8.2 By Company, South Korea Medical Inhaled Nitric Oxide Market Share, 2024
9.8.3 by NO Concentration, South Korea Medical Inhaled Nitric Oxide Market Size, Share, 2024 VS 2031
9.8.4 by Application, South Korea Medical Inhaled Nitric Oxide Market Size, Share, 2024 VS 2031
9.9 Southeast Asia
9.9.1 Southeast Asia Medical Inhaled Nitric Oxide Market Size, 2020-2031
9.9.2 By Company, Southeast Asia Medical Inhaled Nitric Oxide Market Share, 2024
9.9.3 by NO Concentration, Southeast Asia Medical Inhaled Nitric Oxide Market Size, Share, 2024 VS 2031
9.9.4 by Application, Southeast Asia Medical Inhaled Nitric Oxide Market Size, Share, 2024 VS 2031
9.10 India
9.10.1 India Medical Inhaled Nitric Oxide Market Size, 2020-2031
9.10.2 By Company, India Medical Inhaled Nitric Oxide Market Share, 2024
9.10.3 by NO Concentration, India Medical Inhaled Nitric Oxide Market Size, Share, 2024 VS 2031
9.10.4 by Application, India Medical Inhaled Nitric Oxide Market Size, Share, 2024 VS 2031
9.11 Middle East & Africa
9.11.1 Middle East & Africa Medical Inhaled Nitric Oxide Market Size, 2020-2031
9.11.2 By Company, Middle East & Africa Medical Inhaled Nitric Oxide Market Share, 2024
9.11.3 by NO Concentration, Middle East & Africa Medical Inhaled Nitric Oxide Market Size, Share, 2024 VS 2031
9.11.4 by Application, Middle East & Africa Medical Inhaled Nitric Oxide Market Size, Share, 2024 VS 2031

10 Manufacturers Profile
10.1 Mallinckrodt (INOmax)
10.1.1 Mallinckrodt (INOmax) Company Information, Head Office, Market Area, and Industry Position
10.1.2 Mallinckrodt (INOmax) Medical Inhaled Nitric Oxide Models, Specifications, and Application
10.1.3 Mallinckrodt (INOmax) Medical Inhaled Nitric Oxide Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.1.4 Mallinckrodt (INOmax) Company Profile and Main Business
10.1.5 Mallinckrodt (INOmax) Recent Developments
10.2 Linde (Noxivent)
10.2.1 Linde (Noxivent) Company Information, Head Office, Market Area, and Industry Position
10.2.2 Linde (Noxivent) Medical Inhaled Nitric Oxide Models, Specifications, and Application
10.2.3 Linde (Noxivent) Medical Inhaled Nitric Oxide Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.2.4 Linde (Noxivent) Company Profile and Main Business
10.2.5 Linde (Noxivent) Recent Developments
10.3 Air Liquide (KINOX)
10.3.1 Air Liquide (KINOX) Company Information, Head Office, Market Area, and Industry Position
10.3.2 Air Liquide (KINOX) Medical Inhaled Nitric Oxide Models, Specifications, and Application
10.3.3 Air Liquide (KINOX) Medical Inhaled Nitric Oxide Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.3.4 Air Liquide (KINOX) Company Profile and Main Business
10.3.5 Air Liquide (KINOX) Recent Developments

11 Conclusion

12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

According to YH Research, the global market for Medical Inhaled Nitric Oxide should grow from US$ 690 million in 2024 to US$ 954 million by 2031, with a CAGR of 5.6% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Medical Inhaled Nitric Oxide

According to YH Research, the global market for Medical Inhaled Nitric Oxide should grow from US$ 690 million in 2024 to US$ 954 million by 2031, with a CAGR of 5.6% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Inhaled Nitric Oxide (iNO) therapy is a medical treatment involving the inhalation of nitric oxide gas, primarily used to treat conditions such as Acute Respiratory Distress Syndrome (ARDS), pulmonary hypertension, and neonatal pulmonary hypertension. As a gas-based therapy, iNO works by relaxing the smooth muscles of the pulmonary blood vessels, reducing pulmonary vascular resistance, and thereby improving oxygenation and reducing the load on the lungs and heart. iNO is most commonly used in intensive care units (ICUs), particularly for critically ill neonates and adults. Compared to traditional pharmacological treatments, iNO offers a more precise way to regulate blood flow and oxygen supply to the lungs, with fewer side effects. The therapy is delivered through specialized devices, such as inhaled nitric oxide therapy systems, portable inhalation devices, and other apparatus designed to deliver controlled amounts of nitric oxide directly to patients. These devices typically include real-time monitoring of nitric oxide concentration, oxygen levels, and gas flow rates, ensuring precise and safe treatment.

The product range for medical inhaled nitric oxide includes large ICU systems, portable systems, and home-care systems. With advancements in technology, there is an increasing demand for more efficient and user-friendly devices, especially in home-care settings. Portable nitric oxide therapy systems have become particularly important for neonates and adults with chronic conditions, offering both acute and long-term therapeutic benefits. As such, iNO therapy plays an essential role not only in emergency care but also in ongoing treatment for patients with complex respiratory issues.

The medical inhaled nitric oxide (iNO) market is experiencing rapid growth, driven by multiple factors. First, the rising incidence of chronic respiratory diseases and Acute Respiratory Distress Syndrome (ARDS) has significantly increased the demand for iNO therapy. With the aging global population and the high prevalence of lung and cardiovascular diseases, iNO has become an essential treatment option. Particularly in neonatal intensive care, iNO is widely used to treat conditions such as neonatal pulmonary hypertension. Second, with advancements in medical technology, iNO devices are becoming more compact and portable, increasing the accessibility of iNO therapy outside of hospital settings. This shift has opened up vast opportunities for home care and telemedicine solutions, expanding the market.

However, there are risks and challenges in the market. First, the high cost of iNO therapy equipment presents a significant barrier, particularly for healthcare institutions in developing countries. Second, the use of iNO requires specialized equipment and expertise, leading to a need for extensive training for healthcare providers. Furthermore, prolonged use of iNO may lead to potential side effects, such as damage to the lungs or other organs due to high concentrations of nitrogen oxides, necessitating strict monitoring during therapy. The market is also highly concentrated, with a few major players dominating, which could potentially lead to market imbalances in terms of competition.

With ongoing advancements in technology, the performance and reliability of iNO devices continue to improve. Emerging technological trends include more precise gas delivery systems, integrated smart monitoring features, and the development of user-friendly home therapy systems. In the future, the integration of artificial intelligence and big data into iNO therapy could lead to more personalized and intelligent treatment solutions, marking a new direction in the market's evolution.

This report aims to provide a comprehensive study of the global market for Medical Inhaled Nitric Oxide.
Report Highlights:
(1) Global Medical Inhaled Nitric Oxide market size (sales volume & revenue), history data from 2020-2025, and forecast data from 2026 to 2031.

(2) Global Medical Inhaled Nitric Oxide market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(3) China Medical Inhaled Nitric Oxide market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(4) Global Medical Inhaled Nitric Oxide segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global Medical Inhaled Nitric Oxide segment by NO Concentration, and by Application, and regional segment by NO Concentration, and by Application.

(6) Global major production regions of Medical Inhaled Nitric Oxide, capacity, production and trends.

(7) Medical Inhaled Nitric Oxide industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by NO Concentration, covers
High Purity iNO
Standard Purity iNO

Market segment by Application, can be divided into
Infants PPHN
ARDS, etc.

Market segment by players, this report covers
Mallinckrodt (INOmax)
Linde (Noxivent)
Air Liquide (KINOX)